Autor: |
M, Salaga, A, Binienda, P, Draczkowski, P, Kosson, R, Kordek, K, Jozwiak, J, Fichna |
Rok vydání: |
2018 |
Předmět: |
|
Zdroj: |
Peptides. 108 |
ISSN: |
1873-5169 |
Popis: |
Protease inhibition has become a new possible approach in the inflammatory bowel disease (IBD) therapy. A serine exopeptidase, dipeptidyl peptidase IV (DPP IV) is responsible for inactivation of incretin hormone, glucagon-like peptide 2 (GLP-2), a potent stimulator of intestinal epithelium regeneration and growth. Recently we showed that the novel peptide analog of endomorphin-2, EMDB-1 (Tyr-Pro-D-ClPhe-Phe-NH |
Databáze: |
OpenAIRE |
Externí odkaz: |
|